Dr. Robert Osterman Cotes, MD

Dr. Cotes practices at Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority.

Dr. Cotes' NPI, 1275751554, was assigned on April 23, 2007. Dr. Cotes graduated from West Virginia University School Of Medicine in 2007. Dr. Cotes holds Georgia license 065954.

Dr. Cotes' primary practice is Grady Memorial Hospital, at 80 Jesse Hill, Jr Drive SE, Atlanta, GA 30303 in Fulton County. The practice phone is (404) 616-1000.

Dr. Cotes' primary practice is Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority. The medical group on file is Emory Clinic. Dmand AI also links Dr. Cotes to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cotes practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Cotes' primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Cotes is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Cotes' licenses on file in 3 states: Georgia, New Hampshire and Vermont.

Dmand AI lists schizophrenia among the conditions Dr. Cotes treats.

CMS data shows 42 Medicare services from Dr. Cotes across 1 procedure code in 2019, for 15 Medicare patients. Medicare paid $2,484 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Dr. Cotes in 2024. 75% of them have schizophrenia and other psychoses. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cotes' median patient age at 32, with 43% women.

In 2024, Dr. Cotes wrote 474 Medicare Part D claims for 32 patients. 95% of them were for generic drugs. CMS names the drug for 330 of them, across 10 drugs with 11 or more claims each, at $18,557 in total drug cost. In 2023, CMS named 664 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Cotes for performance year 2024, reported as part of a group. Dr. Cotes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cotes as offering telehealth.

Dmand AI links 46 papers to Dr. Cotes, published from 2015 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Antipsychotic Agents, Clozapine and Schizophrenia. Dr. Cotes has published most often in Acad Psychiatry. Dr. Cotes' most frequent co-authors are David Ryan Goldsmith, MD, Ann C. Schwartz, MD and William Maffitt McDonald, MD.

CMS Open Payments shows 72 general payments to Dr. Cotes from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. Aurobindo Pharma USA, Inc. paid the most, $41,817.

Dr. Cotes graduated from West Virginia University School Of Medicine in 2007. Dr. Cotes is a member of APA.

Dr. Cotes is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.